Increased cysteine metabolism in PINK1 models of Parkinson's disease

• Marco Travaglio,
• Filippos Michopoulos,
• Yizhou Yu,
• Rebeka Popovic,
• Edmund Foster,
• Muireann Coen,
• L. Miguel Martins

Affiliations

Marco Travaglio

MRC Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK

Filippos Michopoulos

Oncology R&D, Research & Early Development, AstraZeneca, Cambridge, UK

Yizhou Yu

MRC Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK

Rebeka Popovic

MRC Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK

Edmund Foster

Neuroscience Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK

Muireann Coen

Oncology Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK

L. Miguel Martins

MRC Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK